Network News

Boehringer Ingelheim Stiftung commits €7 million to support the EMBL Imaging Centre in Heidelberg A well-established EMBL partner, Boehringer Ingelheim Stiftung (BIS), is providing €7 million to continue the successful development of the EMBL Imaging Centre (IC). Since its inception, the highly committed staff have positioned the EMBL IC as an internationally leading institution for […]

Reactosome Inc is pioneering the Synthetic Nucleus (SN), a next-generation platform for safe, programmable delivery of large genetic cargo and biologics.Inspired by proteinosomes, SNs are stable, cell-sized compartments with tunable release, capable of delivering 14+ kb DNA or producing RNA/proteins in situ. Validated in vivo with no toxicity, SNs offer a virus-free alternative for gene […]

QuantiLight is a portable blood testing platform for at home monitoring. Millions of patients with chronic diseases require frequent blood monitoring to adapt their medication. Current methods for Therapeutic Drug Monitoring involve taking blood samples in hospitals or laboratories.QuantiLight relieves physicians, laboratories and patients, saving costs and time, and being more convenient for all. If […]

GA International Inc. is a leading manufacturer of specialty labels, supplying laboratory identification solutions to research laboratories, biobanks, hospitals, and other healthcare institutions. Since its inception, GA International has become a worldwide leader in cryogenic and chemical-resistant labels, strongly dedicated to R&D, product development, and manufacturing. If you would like to learn more, please visit […]

Fundess GmbH is a Munich-based consultancy specializing in funding and financing strategies for R&D projects in life sciences and biotech. It supports startups, growth companies, and research institutions in accessing national and European funding, offering strategic planning, proposal development, and execution support with a focus on innovation and impact. If you would like to learn […]

GliTTher is a German biotech company committed to transforming glioblastoma treatment. Its mission is to develop precision therapies that eliminate the cells driving tumour relapse and resistance. Leveraging a unique platform to identify and target aggressive glioma-initiating cells through their metabolic vulnerabilities and companion diagnostics, GliTTher aims to deliver durable solutions to patients.The company envisions […]

WMT tests substances from the “Translational Trap” platform for antiviral and antisepsis effects in cellular assays and animal models Leipzig and Heidelberg, July 21, 2025 The German Federal Agency for Disruptive Innovations (SPRIN-D) and WMT AG in Heidelberg announced today that SPRIN-D has awarded WMT a research contract. WMT will test selected small molecule active […]

Scientists at Heidelberg University’s Faculty of Medicine have developed new analysis methods for special challenges in tumor diagnostics: One provides important information for the classification of tumors within the limited time frame of brain surgery. The other could use artificial intelligence to improve the accuracy of classification when only a small amount of tumor material […]

With its Proof of Concept grants, the European Research Council (ERC) supports scientists in further developing the economic potential of their research results. Two scientists from the German Cancer Research Center (DKFZ) have now received this coveted funding for the second time: Fabricio Loayza-Puch wants to identify unknown immunoactive peptides on tumor cells that can […]